GERRESHEIMER AG (GXI.DE) Stock Price, Forecast & Analysis
FRA:GXI • DE000A0LD6E6
GXI.DE Key Statistics, Chart & Performance
The current stock price of GXI.DE is 16.95 EUR. In the past month the price decreased by -32.79%. In the past year, price decreased by -79%.
GXI.DE Technical Analysis
GXI.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE. Both the profitability and financial health of GXI.DE have multiple concerns.
GXI.DE Financial Highlights
Over the last trailing twelve months GXI.DE reported a non-GAAP Earnings per Share(EPS) of 3.69. The EPS decreased by -19.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.04% | ||
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| Debt/Equity | 1.22 |
GXI.DE Forecast & Estimates
22 analysts have analysed GXI.DE and the average price target is 34.62 EUR. This implies a price increase of 104.26% is expected in the next year compared to the current price of 16.95.
For the next year, analysts expect an EPS growth of -38.18% and a revenue growth 12.69% for GXI.DE
GXI.DE Ownership
GXI.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 39.71 | 17.994B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 34.31 | 17.821B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 34.1 | 17.709B | ||
| SRT | SARTORIUS AG | 31.63 | 14.332B | ||
| QIA | QIAGEN N.V. | 18.39 | 8.644B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 13.04 | 2.226B | ||
| EVT | EVOTEC SE | N/A | 2.088B | ||
| FF | FINE FOODS & PHARMACEUTICALS | 16.56 | 256.448M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 159M |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About GXI.DE
Company Profile
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,535 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
Company Info
GERRESHEIMER AG
Klaus-Bungert-Strasse 4
Dusseldorf NORDRHEIN-WESTFALEN DE
Employees: 13632
Phone: 49211618100
GERRESHEIMER AG / GXI.DE FAQ
What does GERRESHEIMER AG do?
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,535 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
What is the current price of GXI stock?
The current stock price of GXI.DE is 16.95 EUR. The price increased by 7.96% in the last trading session.
Does GERRESHEIMER AG pay dividends?
GERRESHEIMER AG (GXI.DE) has a dividend yield of 0.25%. The yearly dividend amount is currently 1.32.
How is the ChartMill rating for GERRESHEIMER AG?
GXI.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for GXI.DE stock?
22 analysts have analysed GXI.DE and the average price target is 34.62 EUR. This implies a price increase of 104.26% is expected in the next year compared to the current price of 16.95.
What is the GICS sector and industry of GXI stock?
GERRESHEIMER AG (GXI.DE) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Would investing in GERRESHEIMER AG be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GXI.DE.